Randomized, Double-Masked, Parallel Group Study of P-321 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease Assessing Safety and Efficacy Over 28 Days
Latest Information Update: 18 Oct 2018
Price :
$35 *
At a glance
- Drugs P 321 (Primary)
- Indications Dry eyes
- Focus Therapeutic Use
- Sponsors Parion Sciences
- 09 Aug 2017 Status changed from active, no longer recruiting to discontinued.
- 02 Jun 2017 Planned End Date changed from 1 Dec 2016 to 1 Jul 2017.
- 02 Jun 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Jul 2017.